ZY39

Overview

ZY39 is a Sa ClpP agonist. ZY39 promotes the enzymatic hydrolysis of SaClpP and HsClpP in vitro. ZY39 inhibits the growth of Staphylococcus aureus strains. ZY39 reduces the load of Staphylococcus aureus in organs and ascites in mouse peritonitis models and zebrafish infection models, and improves the survival rate of model animals . ZY39 can be used in studies related to Staphylococcus aureus infection , such as peritonitis.

Application

Products | Products > Disease Areas > Pathogens Infection | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Staphylococcus Aureus Infection | Products > Disease Areas > Peritonitis | Products > Disease Areas > Nonalcoholic Steatohepatitis | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > ClpP | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-186109
• CAS No.: 2999673-51-5
• Molecular Formula: C28H35F3N4O4
• Molecular Weight: 548.60
• Purity: 99.73%
• Storage: 4°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (4.56 mM); Clear solution
• Availability: In-stock

Source

Original product source